BioSimilar Solutions
Chemicals & Related Products · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Cll George Sanders, Aguadilla, United St...Phone Number
(408) 338-9339Website
www.biosimilarsolutions.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioSimilar Solutions
Biosimilar Solutions is a leading global company focused on biosimilars that aims to enhance patient lives by increasing access to essential biologic medicines. The company boasts world-class scientific, manufacturing, and commercial capabilities, supported by a unique partnership with a $65 billion biologics developer. It has a low-risk product portfolio set to launch between 2022 and 2025, designed for cost-effective delivery and strong investor returns. The organization is committed to affordability, quality, and expanding access to innovative therapies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioSimilar Solutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioSimilar Solutions is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when BioSimilar Solutions launches new products
Website visits: Recent activity has been detected on your website
Click to see if BioSimilar Solutions had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BioSimilar Solutions has new funding data
BioSimilar Solutions, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioSimilar Solutions recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioSimilar Solutions
Check if BioSimilar Solutions has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BioSimilar Solutions
Find 3 more new buyers
Compare Similar Companies to BioSimilar Solutions
Compare insights from companies similar to BioSimilar Solutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioSimilar Solutions
<$5M
1-10
Private
-
2020
N/A
Company Profile Activity
Activity Insights
BioSimilar Solutions is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioSimilar Solutions is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioSimilar Solutions.
BioSimilar Solutions Tech Stack
A closer look at the technologies used by BioSimilar Solutions
See more technologies
BioSimilar Solutions News & Media
OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product
Biosimilar Solutions, Inc. expects to complete the clinical study in 2022OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico
OcyonBio announces manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. OcyonBio i ...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioSimilar Solutions
Sign Up For FreeTo access detailed company insights
Biosimilar Solutions is a leading global company focused on biosimilars that aims to enhance patient lives by increasing access to essential biologic medicines. The company boasts world-class scientific, manufacturing, and commercial capabilities, supported by a unique partnership with a $65 billion biologics developer. It has a low-risk product po... Read More
